As clinical trials become more complex and patient populations more diverse, the traditional focus on recruitment alone is no longer enough. Building long-term patient relationships grounded in trust, education, and collaboration, is increasingly recognized as essential to trial success. Here, we explore how a patient-centric approach can improve retention, enhance data quality, and ultimately accelerate the development of new treatments.
Recruitment vs. relationship building
Pharmaceutical organizations often face a strategic decision of whether to invest primarily in study recruitment or in building long-term relationships with patients. While successful recruitment strategies are essential for filling trials, a recruitment-focused strategy doesn’t guarantee retention or efficient identification of the most relevant patients. Typically, clinical trials experience a 30% dropout rate, and approximately 40% of a trial's budget is allocated to recruitment efforts. This expenditure can be even greater in the field of precision medicine research, given its complexities.
Alternatively, relationship-building strategies offer long-term benefits by fostering trust and encouraging ongoing participation. By focusing on developing a patient-centric approach, organizations can create a loyal community of engaged patients who are more likely to participate in future trials, provide insightful feedback throughout the research process, and offer greater lifetime value.
Education as a cornerstone
Ensuring that patients are fully informed about research aims, requirements and potential outcomes is key to improving retention and compliance within clinical trials – particularly when addressing the complexities of rare disease. Proactive patient education not only helps to build a more positive patient experience, but plays a significant role in mitigating historical issues such as medication non-adherence, missed clinical visits and premature trial exits. Tailored communications strategies and key updates which clearly explain the role of genetic components, the potential impact of contributing to research, and the future of personalized healthcare can significantly improve trial recruitment and retention rates.
Vitally, personalized patient communications help to foster an ongoing, long-term relationship with participants, helping to increase their emotional investment in the research and creating a culture where they have a strong understanding of how their contribution makes a difference. Additionally, consistent and regular patient communications help ensure that patient expectations and study requirements remain aligned, in turn contributing to improved retention rates and improving the efficiency and cost effectiveness of precision medicine trials.
Increasing patient voice
Working closely with patients to design, develop, and provide feedback on studies is also a significant factor for ensuring that trial designs are optimized from the outset and improving the chances of clinical trial success. Engaging patient voices is key throughout the trial process, from awareness and recruitment, to retention and continued participation in future trial phases. From an investment standpoint, highlighting the impact of patient-centric approaches can help secure buy-in and larger budgets, which are essential for scaling and ultimately adapting research to better serve both patients and scientific development. For example, a study carried out in 2018 reported that investing in patient and public involvement has the potential to accelerate a pre-phase 2 product launch by 2.5 years, or a pre-phase 3 by 1.5 years.
Accelerating adoption
Encouraging a culture of informed risk taking which asks stakeholders to consider the impact of inaction, rather than focus on the potential consequences of innovation, will play a key role in motivating widespread adoption of patient-centered trials. Demonstrating how patient-focused approaches increase retention rates and improve lifetime participation will help to foster creative thinking and innovative practices such as greater utilization of at-home testing and user experience-led design. Finding effective methods and metrics for measuring the impact of patient-centricity will therefore be vital for accelerating adoption, gaining stakeholder buy-in and integrating this type of approach as a universal standard.
Some examples of potential metrics for measuring the impact of patient engagement strategies on trial success include:
- Improved enrollment and retention rates
- Better overall patient satisfaction (although this can be challenging to measure)
- Reduced trial timelines and a reduction in the need for protocol amendments
- Improved data quality and patient compliance
Key takeaway
Moving beyond recruitment to build meaningful, ongoing relationships with patients isn’t just good ethics, it’s good science. Patient-centric engagement leads to better retention, richer feedback, and a more efficient trial process. As the industry continues to evolve, prioritizing education, communication, and collaboration with patients will be key to driving both clinical and commercial success. Now is the time to invest in engagement strategies that don’t end at recruitment, but instead build the foundation for a lasting partnership.
Learn more in our latest whitepaper:
.png)
